GABAAR Modulator for Postpartum Depression
During the postpartum period, the brain’s inhibitory GABAA receptors may not recover in time following their reduced numbers during pregnancy. This is likely the cause of postpartum depression prevalent in ∼12% of childbearing women. A new therapy for this condition consists of administering a synth...
Gespeichert in:
| Veröffentlicht in: | Cell 2019-01, Vol.176 (1-2), p.1-1 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1 |
|---|---|
| container_issue | 1-2 |
| container_start_page | 1 |
| container_title | Cell |
| container_volume | 176 |
| creator | Mody, Istvan |
| description | During the postpartum period, the brain’s inhibitory GABAA receptors may not recover in time following their reduced numbers during pregnancy. This is likely the cause of postpartum depression prevalent in ∼12% of childbearing women. A new therapy for this condition consists of administering a synthetic neurosteroid during the postpartum period to alleviate the mood disorder. To view this Bench to Bedside, open or download the PDF.
During the postpartum period, the brain’s inhibitory GABAA receptors may not recover in time following their reduced numbers during pregnancy. This is likely the cause of postpartum depression prevalent in ∼12% of childbearing women. A new therapy for this condition consists of administering a synthetic neurosteroid during the postpartum period to alleviate the mood disorder. To view this Bench to Bedside, open or download the PDF. |
| doi_str_mv | 10.1016/j.cell.2018.12.016 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2179371972</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0092867418316301</els_id><sourcerecordid>2179371972</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2926-a90a9d7f6b8a40d452939852587cf39817d3da4e74a59150e1f8f56df21209723</originalsourceid><addsrcrecordid>eNp9kE1LxDAQhoMouK7-AU97FKE1kzZNAl7q1yqsKKLnEPMBWbqbmrSC_96UevYwzDC8zzDvi9A54BIwNFfbUtuuKwkGXgIp8-oALQALVtTAyCFaYCxIwRtWH6OTlLYYY04pXaDLdXvTtm-r52DGTg0hrlyu15CGXsVh3K3ubB9tSj7sT9GRU12yZ399iT4e7t9vH4vNy_rptt0UmgjSFEpgJQxzzSdXNTY1JaISnBLKmXZ5AmYqo2rLakUFUGzBcUcb4wiQ_DCpluhivtvH8DXaNMidT5M9tbdhTJIAExWDWUpmqY4hpWid7KPfqfgjAcspGLmVEymnYCQQmVcZup4hm018extl0t7utTU-Wj1IE_x_-C8K32lj</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2179371972</pqid></control><display><type>article</type><title>GABAAR Modulator for Postpartum Depression</title><source>Elsevier ScienceDirect Journals Complete - AutoHoldings</source><source>Cell Press Free Archives</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Mody, Istvan</creator><creatorcontrib>Mody, Istvan</creatorcontrib><description>During the postpartum period, the brain’s inhibitory GABAA receptors may not recover in time following their reduced numbers during pregnancy. This is likely the cause of postpartum depression prevalent in ∼12% of childbearing women. A new therapy for this condition consists of administering a synthetic neurosteroid during the postpartum period to alleviate the mood disorder. To view this Bench to Bedside, open or download the PDF.
During the postpartum period, the brain’s inhibitory GABAA receptors may not recover in time following their reduced numbers during pregnancy. This is likely the cause of postpartum depression prevalent in ∼12% of childbearing women. A new therapy for this condition consists of administering a synthetic neurosteroid during the postpartum period to alleviate the mood disorder. To view this Bench to Bedside, open or download the PDF.</description><identifier>ISSN: 0092-8674</identifier><identifier>EISSN: 1097-4172</identifier><identifier>DOI: 10.1016/j.cell.2018.12.016</identifier><language>eng</language><publisher>Elsevier Inc</publisher><ispartof>Cell, 2019-01, Vol.176 (1-2), p.1-1</ispartof><rights>2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2926-a90a9d7f6b8a40d452939852587cf39817d3da4e74a59150e1f8f56df21209723</citedby><cites>FETCH-LOGICAL-c2926-a90a9d7f6b8a40d452939852587cf39817d3da4e74a59150e1f8f56df21209723</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.cell.2018.12.016$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,3549,27923,27924,45994</link.rule.ids></links><search><creatorcontrib>Mody, Istvan</creatorcontrib><title>GABAAR Modulator for Postpartum Depression</title><title>Cell</title><description>During the postpartum period, the brain’s inhibitory GABAA receptors may not recover in time following their reduced numbers during pregnancy. This is likely the cause of postpartum depression prevalent in ∼12% of childbearing women. A new therapy for this condition consists of administering a synthetic neurosteroid during the postpartum period to alleviate the mood disorder. To view this Bench to Bedside, open or download the PDF.
During the postpartum period, the brain’s inhibitory GABAA receptors may not recover in time following their reduced numbers during pregnancy. This is likely the cause of postpartum depression prevalent in ∼12% of childbearing women. A new therapy for this condition consists of administering a synthetic neurosteroid during the postpartum period to alleviate the mood disorder. To view this Bench to Bedside, open or download the PDF.</description><issn>0092-8674</issn><issn>1097-4172</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNp9kE1LxDAQhoMouK7-AU97FKE1kzZNAl7q1yqsKKLnEPMBWbqbmrSC_96UevYwzDC8zzDvi9A54BIwNFfbUtuuKwkGXgIp8-oALQALVtTAyCFaYCxIwRtWH6OTlLYYY04pXaDLdXvTtm-r52DGTg0hrlyu15CGXsVh3K3ubB9tSj7sT9GRU12yZ399iT4e7t9vH4vNy_rptt0UmgjSFEpgJQxzzSdXNTY1JaISnBLKmXZ5AmYqo2rLakUFUGzBcUcb4wiQ_DCpluhivtvH8DXaNMidT5M9tbdhTJIAExWDWUpmqY4hpWid7KPfqfgjAcspGLmVEymnYCQQmVcZup4hm018extl0t7utTU-Wj1IE_x_-C8K32lj</recordid><startdate>20190110</startdate><enddate>20190110</enddate><creator>Mody, Istvan</creator><general>Elsevier Inc</general><scope>6I.</scope><scope>AAFTH</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20190110</creationdate><title>GABAAR Modulator for Postpartum Depression</title><author>Mody, Istvan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2926-a90a9d7f6b8a40d452939852587cf39817d3da4e74a59150e1f8f56df21209723</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mody, Istvan</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Cell</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mody, Istvan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>GABAAR Modulator for Postpartum Depression</atitle><jtitle>Cell</jtitle><date>2019-01-10</date><risdate>2019</risdate><volume>176</volume><issue>1-2</issue><spage>1</spage><epage>1</epage><pages>1-1</pages><issn>0092-8674</issn><eissn>1097-4172</eissn><abstract>During the postpartum period, the brain’s inhibitory GABAA receptors may not recover in time following their reduced numbers during pregnancy. This is likely the cause of postpartum depression prevalent in ∼12% of childbearing women. A new therapy for this condition consists of administering a synthetic neurosteroid during the postpartum period to alleviate the mood disorder. To view this Bench to Bedside, open or download the PDF.
During the postpartum period, the brain’s inhibitory GABAA receptors may not recover in time following their reduced numbers during pregnancy. This is likely the cause of postpartum depression prevalent in ∼12% of childbearing women. A new therapy for this condition consists of administering a synthetic neurosteroid during the postpartum period to alleviate the mood disorder. To view this Bench to Bedside, open or download the PDF.</abstract><pub>Elsevier Inc</pub><doi>10.1016/j.cell.2018.12.016</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0092-8674 |
| ispartof | Cell, 2019-01, Vol.176 (1-2), p.1-1 |
| issn | 0092-8674 1097-4172 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2179371972 |
| source | Elsevier ScienceDirect Journals Complete - AutoHoldings; Cell Press Free Archives; EZB-FREE-00999 freely available EZB journals |
| title | GABAAR Modulator for Postpartum Depression |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T07%3A29%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=GABAAR%20Modulator%20for%20Postpartum%20Depression&rft.jtitle=Cell&rft.au=Mody,%20Istvan&rft.date=2019-01-10&rft.volume=176&rft.issue=1-2&rft.spage=1&rft.epage=1&rft.pages=1-1&rft.issn=0092-8674&rft.eissn=1097-4172&rft_id=info:doi/10.1016/j.cell.2018.12.016&rft_dat=%3Cproquest_cross%3E2179371972%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2179371972&rft_id=info:pmid/&rft_els_id=S0092867418316301&rfr_iscdi=true |